FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1570562883> ?p ?o ?g. }

• W1570562883 endingPage "659" @default.
• W1570562883 startingPage "645" @default.
• W1570562883 abstract "Please cite this paper as: Cotton S, Sharp L, Little J, Cruickshank M, Seth R, Smart L, Duncan I, Harrild K, Neal K, Waugh N, The TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) Group. The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial. BJOG 2010; DOI: 10.1111/j.1471-0528.2010.02519.x. Objective To assess the value of a single human papillomavirus (HPV) test in making decisions on management of women with cervical cytology showing borderline nuclear abnormality (BNA) or mild dyskaryosis. In particular, to determine whether information on high-risk (hr) HPV status would be valuable in the choice between (1) cytological surveillance versus immediate referral to colposcopy, and (2) at colposcopy, between biopsy and recall versus immediate large loop excision of the transformation zone (LLETZ). Design Multicentre individually randomised controlled trial, nested within the NHS Cervical Screening Programmes, investigating the value of HPV testing by testing for interactions between HPV status and (1) cytological surveillance versus colposcopy, and (2) biopsy and recall versus immediate LLETZ. Setting Grampian, Tayside and Nottingham. Population Women (n = 4439), aged 20–59 years, with a cytology test showing borderline nuclear abnormalities or mild dyskaryosis during October 1999 to October 2002. Methods High-risk HPV status was determined at recruitment using the polymerase chain reaction assay with the GP5+/6+ general primer system. The results of this HPV testing were not disclosed to either the participating women or to those involved in their management. Women were randomised to either (1) 6-monthly cytological screening in primary care or (2) referral for colposcopy. Human papillomavirus status was used to stratify both randomisations. All women were followed for 3 years, concluding with an invitation to an exit appointment at which colposcopic examination was undertaken. In addition, in women who were randomised to initial colposcopy and underwent colposcopy, the association between hrHPV status and presence of cervical intraepithelial neoplasia (CIN) grade 2 or more severe disease (henceforth CIN2 or worse) was examined. Main outcome measures Sensitivity, specificity, positive and negative predictive values of the HPV test for predicting CIN2 or worse and the implications for the choice of management between cytological surveillance and immediate referral for colposcopy. Results There were no significant interactions between management and HPV status. Hence, in women with mild dyskaryosis or BNA who are HPV positive, there is no advantage of (1) immediate colposcopy over cytological surveillance (P = 0.76) or (2) immediate LLETZ over biopsy and recall (P = 0.27). The sensitivity of HPV testing for detection of CIN2 or worse was 75.2% (95% CI 68.8–81.0%) among women with mild dyskaryosis and 69.9% (95% CI 61.7–77.3%) among those with BNA. Specificity was higher in those with BNA (71.3%; 95% CI 68.5–74.1%) than in those with mild dyskaryosis (46.9%; 95% CI 42.2–51.6%). Sensitivity decreased with increasing age whereas specificity increased. The negative predictive value was high, particularly among women with BNA (94.5%; 95% CI 92.9–96.0%). Across all ages, 22% of women who had CIN2 or worse were HPV negative. Conversely, 40% of those who were HPV positive did not have CIN. HPV was a much more reliable predictor in women aged over 40 years. Conclusions We conclude that in younger women with low-grade cytological abnormalities, a single HPV test would not be useful in determining who should be referred for colposcopy or the most effective management at colposcopy. In women over 40, a negative HPV test could be used to rule out further investigation." @default.
• W1570562883 created "2016-06-24" @default.
• W1570562883 creator A5006389683 @default.
• W1570562883 creator A5009008744 @default.
• W1570562883 creator A5019155992 @default.
• W1570562883 creator A5025345555 @default.
• W1570562883 creator A5050682858 @default.
• W1570562883 creator A5068981280 @default.
• W1570562883 creator A5069525601 @default.
• W1570562883 creator A5073764742 @default.
• W1570562883 creator A5085045412 @default.
• W1570562883 creator A5021745579 @default.
• W1570562883 date "2010-03-18" @default.
• W1570562883 modified "2023-10-16" @default.
• W1570562883 title "The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial" @default.
• W1570562883 cites W1571036433 @default.
• W1570562883 cites W1968258823 @default.
• W1570562883 cites W1975907409 @default.
• W1570562883 cites W1980750660 @default.
• W1570562883 cites W1985590595 @default.
• W1570562883 cites W1988590161 @default.
• W1570562883 cites W1989346822 @default.
• W1570562883 cites W1989850029 @default.
• W1570562883 cites W1992515073 @default.
• W1570562883 cites W1999018641 @default.
• W1570562883 cites W2017063993 @default.
• W1570562883 cites W2031135517 @default.
• W1570562883 cites W2031975753 @default.
• W1570562883 cites W2035348064 @default.
• W1570562883 cites W2035470909 @default.
• W1570562883 cites W2035608162 @default.
• W1570562883 cites W2043493330 @default.
• W1570562883 cites W2050199184 @default.
• W1570562883 cites W2053769064 @default.
• W1570562883 cites W2060018882 @default.
• W1570562883 cites W2062728664 @default.
• W1570562883 cites W2095688730 @default.
• W1570562883 cites W2101196984 @default.
• W1570562883 cites W2105501053 @default.
• W1570562883 cites W2118431227 @default.
• W1570562883 cites W2123070859 @default.
• W1570562883 cites W2123473008 @default.
• W1570562883 cites W2130272997 @default.
• W1570562883 cites W2135081972 @default.
• W1570562883 cites W2136184118 @default.
• W1570562883 cites W2141921059 @default.
• W1570562883 cites W2148272663 @default.
• W1570562883 cites W2153952034 @default.
• W1570562883 cites W2155105463 @default.
• W1570562883 cites W2166632132 @default.
• W1570562883 cites W2274125318 @default.
• W1570562883 cites W2593799506 @default.
• W1570562883 cites W3143504308 @default.
• W1570562883 cites W333391747 @default.
• W1570562883 cites W4238851090 @default.
• W1570562883 cites W4240777490 @default.
• W1570562883 cites W4242259207 @default.
• W1570562883 cites W4253186498 @default.
• W1570562883 cites W4254301318 @default.
• W1570562883 cites W4362208337 @default.
• W1570562883 cites W4376043977 @default.
• W1570562883 cites W4377996028 @default.
• W1570562883 doi "https://doi.org/10.1111/j.1471-0528.2010.02519.x" @default.
• W1570562883 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20374607" @default.
• W1570562883 hasPublicationYear "2010" @default.
• W1570562883 type Work @default.
• W1570562883 sameAs 1570562883 @default.
• W1570562883 citedByCount "21" @default.
• W1570562883 countsByYear W15705628832012 @default.
• W1570562883 countsByYear W15705628832013 @default.
• W1570562883 countsByYear W15705628832014 @default.
• W1570562883 countsByYear W15705628832016 @default.
• W1570562883 countsByYear W15705628832017 @default.
• W1570562883 countsByYear W15705628832018 @default.
• W1570562883 countsByYear W15705628832020 @default.
• W1570562883 crossrefType "journal-article" @default.
• W1570562883 hasAuthorship W1570562883A5006389683 @default.
• W1570562883 hasAuthorship W1570562883A5009008744 @default.
• W1570562883 hasAuthorship W1570562883A5019155992 @default.
• W1570562883 hasAuthorship W1570562883A5021745579 @default.
• W1570562883 hasAuthorship W1570562883A5025345555 @default.
• W1570562883 hasAuthorship W1570562883A5050682858 @default.
• W1570562883 hasAuthorship W1570562883A5068981280 @default.
• W1570562883 hasAuthorship W1570562883A5069525601 @default.
• W1570562883 hasAuthorship W1570562883A5073764742 @default.
• W1570562883 hasAuthorship W1570562883A5085045412 @default.
• W1570562883 hasBestOaLocation W15705628831 @default.
• W1570562883 hasConcept C121608353 @default.
• W1570562883 hasConcept C126322002 @default.
• W1570562883 hasConcept C131872663 @default.
• W1570562883 hasConcept C142724271 @default.
• W1570562883 hasConcept C168563851 @default.
• W1570562883 hasConcept C18823058 @default.
• W1570562883 hasConcept C2775934546 @default.
• W1570562883 hasConcept C2776117191 @default.
• W1570562883 hasConcept C2777343196 @default.
• W1570562883 hasConcept C2778220009 @default.
• W1570562883 hasConcept C2780647465 @default.

• next